A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2001
10/25/2001	CA2406472A1 Javelinization of protein antigens to heat shock proteins
10/25/2001	CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	CA2406390A1 Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406245A1 Il-174 uses, compositions and methods
10/25/2001	CA2406195A1 Lipid binding protein 4
10/25/2001	CA2406180A1 Viruses comprising mutant ion channel protein
10/25/2001	CA2406140A1 Methods for measuring drug resistance
10/25/2001	CA2405919A1 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001	CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405377A1 Nutritional modules
10/25/2001	CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/24/2001	EP1148050A1 Retroviral protease inhibitors
10/24/2001	EP1147771A1 Pharmaceutical formulation containing amoxycillin and clavulanate
10/24/2001	EP1147770A1 Virginiamycin mixture
10/24/2001	EP1147422A1 Assays for modulators of "elongation factor p" activity
10/24/2001	EP1147227A1 Lipophilic quenching of viral inactivating agents
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1147108A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/24/2001	EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146913A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
10/24/2001	EP1146906A1 Mucosal delivery system
10/24/2001	EP1146904A1 Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv
10/24/2001	EP1146900A2 Dna vaccines against hantavirus infections
10/24/2001	EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001	EP1146889A2 Identification of specific differentially expressed mycobacterial antigens
10/24/2001	EP1146883A1 Modulation of immune response by ribavirin
10/24/2001	EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
10/24/2001	EP1146880A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
10/24/2001	EP1146867A1 Antibacterial hydroxamic acid derivatives
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0921791B1 Composition comprising mupirocin and chlorhexidine
10/24/2001	EP0910405B1 Vaccine containing caprine arthritis-encephalitis virus and use for immunoprotection against hiv-1 infection
10/24/2001	EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
10/24/2001	EP0828511B1 Haemophilus influenzae type b vaccine composition containing polyribosylribitol phosphate and method for making the same
10/24/2001	EP0755393B1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine
10/24/2001	EP0731801B1 Substituted aminoalkylaminopyridines
10/24/2001	EP0721957B1 Compound ge3
10/24/2001	EP0711163B1 Use of benzydamine in the treatment of pathological conditions caused by tnf
10/24/2001	EP0593754B1 Peptides of human papilloma virus for use in human t cell response inducing compositions
10/24/2001	CN1319140A Recombinant CELO virus and CELO virus DNA
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319006A Use of organophosphorous compounds for producing medicaments for therapeutic and prophylactic treatment of infections or as fungicide, bactericide or herbicide for plants
10/24/2001	CN1318646A Coded salmonella typhi specific and antigenic outer membrane protein DNA sequence
10/24/2001	CN1318565A Humanized hapotitis A virus neutralizing genetically engineered total antibody
10/24/2001	CN1318541A Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application
10/24/2001	CN1318399A Radix Isatidis injecta and its preparation
10/24/2001	CN1318392A Beriberi treating ointment
10/24/2001	CN1318389A Vaginitis-treating compound Chinese and Western medicine preparation
10/24/2001	CN1318378A Heat syndrome treating Chinese medicine
10/24/2001	CN1318371A New use of flavone
10/24/2001	CN1318369A Preparation of oral coated medicine grains
10/24/2001	CN1318365A Vanishing cream for treating tinea pedis and ringworm of nails
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073441C Broad-spectrum antibacterial medicine
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307080 Water-soluble zinc pyruvates or their hydrates, method for the product ion thereof and their use
10/23/2001	US6307059 Preparation of quinolone antibiotics.
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307043 For treatment or prophylaxis of herpes viral infections
10/23/2001	US6307022 Def
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306899 Viricides
10/23/2001	US6306865 Pharmaceutically active benzoquinazoline compounds
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001	US6306854 Chemical compounds
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306838 Targeted vesicular constructs for cyto protection and treatment of h. pylori
10/23/2001	US6306663 Controlling protein levels in eucaryotic organisms
10/23/2001	US6306655 Antisense inhibition of C/EBP alpha expression
10/23/2001	US6306623 Leptospiral major outer membrane protein LipL32
10/23/2001	US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor
10/23/2001	US6306579 Immunoassay by incubating sample with at least one peptide from ns3 region having at least one covalently modified cysteine or replaced cysteine, then determining binding of antibody to peptide
10/23/2001	US6306405 Use of microparticles combined with submicron oil-in-water emulsions
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306400 For immunization of chickens
10/23/2001	US6306397 Variants of human papilloma virus antigens
10/23/2001	US6306385 Method of protecting against chronic infections
10/23/2001	US6305380 Administering histamine agonist or ht3 receptor antagonist to activate natural killer cells and treat viral diseases
10/23/2001	CA2302963C Soft gelatin capsule manufacture
10/23/2001	CA2040058C Alpha-mannosidase and fucosidase inhibitors

1 ... 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 ... 1798